- Home
- VOC vs NRXP Comparison
VOC vs NRXP Comparison
Compare VOC & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOC
- NRXP
- Stock Information
- Founded
- VOC 2010
- NRXP 2015
- Country
- VOC United States
- NRXP United States
- Employees
- VOC N/A
- NRXP N/A
- Industry
- VOC Oil & Gas Production
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- VOC Energy
- NRXP Health Care
- Exchange
- VOC Nasdaq
- NRXP Nasdaq
- Market Cap
- VOC 51.3M
- NRXP 58.5M
- IPO Year
- VOC 2011
- NRXP N/A
- Fundamental
- Price
- VOC $2.73
- NRXP $2.32
- Analyst Decision
- VOC
- NRXP Strong Buy
- Analyst Count
- VOC 0
- NRXP 4
- Target Price
- VOC N/A
- NRXP $29.25
- AVG Volume (30 Days)
- VOC 90.4K
- NRXP 495.0K
- Earning Date
- VOC 01-01-0001
- NRXP 08-18-2025
- Dividend Yield
- VOC 23.06%
- NRXP N/A
- EPS Growth
- VOC N/A
- NRXP N/A
- EPS
- VOC 0.57
- NRXP N/A
- Revenue
- VOC $11,024,911.00
- NRXP N/A
- Revenue This Year
- VOC N/A
- NRXP N/A
- Revenue Next Year
- VOC N/A
- NRXP $231.16
- P/E Ratio
- VOC $4.71
- NRXP N/A
- Revenue Growth
- VOC N/A
- NRXP N/A
- 52 Week Low
- VOC $2.44
- NRXP $1.10
- 52 Week High
- VOC $5.69
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- VOC 44.18
- NRXP 37.39
- Support Level
- VOC $2.64
- NRXP $2.40
- Resistance Level
- VOC $2.78
- NRXP $2.83
- Average True Range (ATR)
- VOC 0.11
- NRXP 0.22
- MACD
- VOC 0.01
- NRXP -0.00
- Stochastic Oscillator
- VOC 52.00
- NRXP 8.70
About VOC VOC Energy Trust Units of Beneficial Interest
VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.